Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Baird Downgrades UserTesting to Neutral

Baird Downgrades UserTesting to Neutral

Baird analyst Rob Oliver downgrades UserTesting (NYSE:USER) from Outperform to Neutral.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Baird analyst Rob Oliver downgrades UserTesting (NYSE:USER) from Outperform to Neutral.

Is Apple Eyeing A New Partner For Apple Card Issuance? This Job Listing May Give A Clue

By Benzinga Neuro

November 30, 6:29 AM

The job description provided some hints about Apple's plans, mentioning in particular a collaboration with Brazilian fintech company Pismo.

AAPL

Kineta Provides Update On Its Ongoing Phase 1/2 VISTA-101 Clinical Trial Of KVA12123 In Patients With Advanced Solid Tumors

By Benzinga Newsdesk

January 17, 9:31 AM

Cleared First Four Monotherapy Doses and Initial Combination Cohort with No Dose Limiting Toxicities at any Dose LevelKVA12123 Monotherapy Demonstrated Dose Proportional Induction of Pro-inflammatory Biomarkers Required

Meta Owned Instagram and Facebook Plagued With Pedophile Networks And Its Algorithms Are Not Helping: Report

By Anusuya Lahiri

December 1, 9:59 AM

Meta Platforms Inc (NASDAQ: META), the owner of Instagram and Facebook, is grappling with

The Latest Analyst Ratings For Leidos Holdings

By Benzinga Insights

February 14, 4:00 PM

5 analysts have expressed a variety of opinions on Leidos Holdings (NYSE:LDOS) over the past quarter, offering a…

LDOS

Baird Downgrades UserTesting to Neutral

Related Posts

Is Apple Eyeing A New Partner For Apple Card Issuance? This Job Listing May Give A Clue

Kineta Provides Update On Its Ongoing Phase 1/2 VISTA-101 Clinical Trial Of KVA12123 In Patients With Advanced Solid Tumors

Meta Owned Instagram and Facebook Plagued With Pedophile Networks And Its Algorithms Are Not Helping: Report

The Latest Analyst Ratings For Leidos Holdings